De. Chapman et al., INDUCTION IN-VITRO AND COMPLETE CODING REGION SEQUENCE OF CYTOCHROME P4501A1 CDNA FROM CULTURED WHOLE RAT CONCEPTUSES DURING EARLY ORGANOGENESIS, Biochemical pharmacology, 48(9), 1994, pp. 1807-1814
Exposures of cultured whole rat conceptuses during organogenesis to 3-
methylcholanthrene (MC; 0.025-25 mu M), 5,6-benzoflavone (BNF; 5-100 m
u M) or benz[a]anthracene (BA; 5-100 mu M) were effected by placement
of each of these ''MC-type'' inducing agents in the culture medium at
the time of explantation on day 9.5 of gestation. Conceptuses were the
n cultured for 48 hr and evaluated on day 11.5 for increased expressio
n of inducible conceptal cytochrome P450 (P450). The three agents each
elicited concentration-dependent increases in 7,8-benzoflavone (ANF)-
inhibitable ethoxyresorufin O-deethylase (EROD) activities and increas
ed P4501A1 mRNA as detected by primer-specific reverse transcriptase-p
olymerase chain reaction (RT-PCR) in cell-free preparations of the tre
ated, cultured conceptuses. At effective inducing concentrations, dysm
orphogenic or other embryotoxic effects were not detectable. At 20 mu
M concentrations, the three agents exhibited roughly equal induction t
hat was approximately equivalent in magnitude (6- to 13-fold) to that
achieved previously with exposures to MC in utero. Additions to the cu
lture medium of 2.5 to 10 mu M concentrations of dexamethasone (DEX) d
id not alter significantly the magnitude of MC-elicited induction in v
itro. Repeated full-length sequencing of an RT-PCR-amplified cDNA reve
aled a coding region sequence identical to that reported for the P4501
A1 sequence from adult rat liver. The results provide a basis for inve
stigations, in the absence of maternal influences, of the regulation o
f mammalian conceptal P4501A1 in intact tissues during organogenesis,
a gestational period critical in terms of the dysmorphogenic and other
embryotoxic effects of foreign organic chemicals. The results are als
o pertinent to studies of embryotoxicity, particularly to the transpla
cental carcinogenicity, mutagenicity and dysmorphogenicity of P4501A1
substrates.